Assessment of tissue-engineered islet graft viability by fluorine magnetic resonance spectroscopy

Transplantation Proceedings

Volumn 43, Issue 9, 2011, Pages 3221-3225

  Suszynski, T M ^a   Avgoustiniatos, E S ^a   Stein, S A ^a   Falde, E J ^a   Hammer, B E ^a   Papas, K K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUORODECALIN; TISSUE SCAFFOLD;

CALIBRATION; CONFERENCE PAPER; CULTURE MEDIUM; DOSE RESPONSE; FLUORINE NUCLEAR MAGNETIC RESONANCE; HUMAN; HUMAN CELL; OXYGEN CONSUMPTION; OXYGEN TENSION; PANCREAS ISLET CELL; PRIORITY JOURNAL; RELAXATION TIME; STEADY STATE; TISSUE ENGINEERING; TISSUE GRAFT;

ANIMALS; CELL SURVIVAL; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORINE; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, THEORETICAL; OXYGEN; OXYGEN CONSUMPTION; PARTIAL PRESSURE; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 81455139631     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.09.009     Document Type: Conference Paper

References (38)

1. B.J. Hering, R. Kandaswamy, and J.D. Ansite Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes JAMA 293 2005 830
2. E.A. Ryan, and A.J. Shapiro A patient with severe, recurrent hypoglycemia and glycemic lability who underwent islet transplantation Nat Clin Pract Endocrinol Metab 2 2006 349 quiz 354
3. A. Gangemi, P. Salehi, and B. Hatipoglu Islet transplantation for brittle type 1 diabetes: the UIC protocol Am J Transplant 8 2008 1250
4. A.M. Shapiro, C. Ricordi, and B.J. Hering International trial of the Edmonton protocol for islet transplantation N Engl J Med 355 2006 1318
5. M.D. Bellin, R. Kandaswamy, and J. Parkey Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes Am J Transplant 8 2008 2463
6. A. Koh, S. Imes, and T. Kin Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients Transplantation 89 2010 361
7. A. Koh, P. Senior, and A. Salam Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success Transplantation 89 2010 465
8. A.M. Posselt, M.D. Bellin, and M. Tavakol Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab Am J Transplant 10 2010 1870
9. M.D. Bellin, D.E. Sutherland, and G.J. Beilman Similar islet function in islet allotransplant and autotransplant recipients, despite lower islet mass in autotransplants Transplantation 91 2011 367
10. E. Rafael, A. Tibell, and M. Ryden Intramuscular autotransplantation of 2 pancreatic islets in a 7-year-old child: a 2-year follow-up Am J Transplant 8 2008 458
11. D.M. Berman, J.J. O'Neil, and L.C. Coffe Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold Am J Transplant 9 2009 91
12. A.M. Shapiro, H. Gallant, and E. Hao Portal vein immunosuppressant levels and islet graft toxicity Transplant Proc 30 1998 641 (Pubitemid 28207334)
13. N.M. Desai, J.A. Goss, and S. Deng Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation 76 2003 1623
14. K. Tamura, T. Fujimura, and T. Tsutsumi Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell Transplantation 59 1995 1606
15. B.W. Paty, J.S. Harmon, and C.L. Marsh Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets Transplantation 73 2002 353
16. E. Bell, X. Cao, and J.A. Moibi Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets Diabetes 52 2003 2731
17. M. Laugharne, S. Cross, and S. Richards Sirolimus toxicity and vascular endothelial growth factor release from islet and renal cell lines Transplantation 83 2007 1635
18. W. Bennet, B. Sundberg, and C.G. Groth Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48 1999 1907
19. W. Bennet, B. Sundberg, and T. Lundgren Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin Transplantation 69 2000 711
20. M. Goto, J. Tjernberg, and D. Dufrane Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation Xenotransplantation 15 2008 225
21. F. Thomas, J. Wu, and J.L. Contreras A tripartite anoikis-like mechanism causes early isolated islet apoptosis Surgery 130 2001 333
22. G.G. Pinkse, W.P. Bouwman, and R. Jiawan-Lalai Integrin signaling via RGD peptides and anti-beta1 antibodies confers resistance to apoptosis in islets of Langerhans Diabetes 55 2006 312
23. N. Tygstrup, K. Winkler, and K. Mellemgaard Determination of the hepatic arterial blood flow and oxygen supply in man by clamping the hepatic artery during surgery J Clin Invest 41 1962 447
24. G.E. Arteel, R.G. Thurman, and J.M. Yates Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver Br J Cancer 72 1995 889
25. N. Sekine, V. Cirulli, and R. Regazzi Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells Potential role in nutrient sensing J Biol Chem 269 1994 4895
26. K.K. Papas, C.K. Colton, and J.S. Gounarides NMR spectroscopy in beta cell engineering and islet transplantation Ann N Y Acad Sci 944 2001 96
27. M. Giuliani, W. Moritz, and E. Bodmer Central necrosis in isolated hypoxic human pancreatic islets: evidence for postisolation ischemia Cell Transplant 14 2005 67
28. K.K. Papas, T.M. Suszynski, and C.K. Colton Islet assessment for transplantation Curr Opin Organ Transplant 14 2009 674
29. W. Wang, L. Upshaw, and D.M. Strong Increased oxygen consumption rates in response to high glucose detected by a novel oxygen biosensor system in non-human primate and human islets J Endocrinol 185 2005 445
30. C. Fraker, M.R. Timmins, and R.D. Guarino The use of the BD oxygen biosensor system to assess isolated human islets of langerhans: oxygen consumption as a potential measure of islet potency Cell Transplant 15 2006 745
31. I.R. Sweet, and M. Gilbert Contribution of calcium influx in mediating glucose-stimulated oxygen consumption in pancreatic islets Diabetes 55 2006 3509
32. K.K. Papas, A. Pisania, and H. Wu A stirred microchamber for oxygen consumption rate measurements with pancreatic islets Biotechnol Bioeng 98 2007 1071
33. K.K. Papas, C.K. Colton, and R.A. Nelson Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice Am J Transplant 7 2007 707
34. I.R. Sweet, M. Gilbert, and S. Scott Glucose-stimulated increment in oxygen consumption rate as a standardized test of human islet quality Am J Transplant 8 2008 183
35. K.K. Papas, C.K. Colton, and A. Qipo Prediction of marginal mass required for successful islet transplantation J Invest Surg 23 2010 28
36. E.S. Avgoustiniatos, and C.K. Colton Effect of external oxygen mass transfer resistances on viability of immunoisolated tissue Ann N Y Acad Sci 831 1997 145
37. E.S. Avgoustiniatos, and C.K. Colton Design considerations in immunoisolation R.P. Lanza, R. Langer, W.L. Chick, Principles of Tissue Engineering 1997 Landes RG Austin, Tex 333
38. C.K. Colton, K.K. Papas, and A. Pisania Characterizations of Islet Preparations, Cellular Transplantation: From Laboratory to Clinic 2007 Academic Press San Diego 85